icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Clinical Added Value
no clinical added value
NEVANAC 1 mg/ ml, eye drops, suspension does not offer any improvement in actual benefit (IAB V) over standard management of postoperative macular oedema associated with cataract surgery in diabetic patients.
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
Cq0hremDhY5t229B
Listen
